Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teruhiko Fujii

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 31, 2004
[Molecular targeting drugs--present status and future development]Michihiko Kuwano, Teruhiko Fujii, Mayumi Ono, et al.
International Journal of Oncology|November 14, 2002
Analysis of cell growth inhibitory effects of catechin through MAPK in human breast cancer cell line T47DHiroko Deguchi, Teruhiko Fujii, Shino Nakagawa, et al.
International Journal of Molecular Medicine|August 8, 2002
Prevention of carcinogenesis of mouse mammary epithelial cells RIII/MG by epigallocatechin gallateHiroshi Yanaga, Teruhiko Fujii, Toshihiro Koga, et al.
Journal of Oncology|September 28, 2010
Apparent Diffusion Coefficient in Invasive Ductal Breast Carcinoma: Correlation with Detailed Histologic Features and the Enhancement Ratio on Dynamic Contrast-Enhanced MR ImagesRoka Namoto Matsubayashi, Teruhiko Fujii, Kotaro Yasumori, et al.
Breast Cancer Research and Treatment|June 26, 2004
Identification of HER2/ neu-derived peptides capable of inducing both cellular and humoral immune responses in HLA-A24 positive breast cancer patientsKoichi Azuma, Shigeki Shichijo, Hiroki Shomura, et al.
Cancer Immunology, Immunotherapy : CII|December 20, 2005
Characterization of IL-2-activated TILs and their use in intrapericardial immunotherapy in malignant pericardial effusionUhi Toh, Teruhiko Fujii, Naoko Seki, et al.
The Japanese Journal of Thoracic and Cardiovascular Surgery : Official Publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai Zasshi|January 14, 2004
Spontaneous regression in small cell esophageal carcinomaMasahiro Kubota, Susumu Sueyoshi, Hiromasa Fujita, et al.
International Journal of Molecular Medicine|September 18, 2004
Experimental gene therapy using p21Waf1 gene for esophageal squamous cell carcinoma by gene gun technologyYuichi Tanaka, Teruhiko Fujii, Hideaki Yamana, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 19, 2008
[A case of recurrent breast cancer with bone marrow metastasis treated with weekly paclitaxel therapy]Shinsuke Sasada, Goro Yokoyama, Hiroki Takahashi, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|May 7, 2004
Cyclin-dependent kinase inhibitor, p21Waf1, regulates vascular smooth muscle cell hypertrophyKenichi Okamoto, Seiya Kato, Nobuyuki Arima, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 31, 2004
[Molecular targeting drugs--present status and future development]Michihiko Kuwano, Teruhiko Fujii, Mayumi Ono, et al.
International Journal of Oncology|November 14, 2002
Analysis of cell growth inhibitory effects of catechin through MAPK in human breast cancer cell line T47DHiroko Deguchi, Teruhiko Fujii, Shino Nakagawa, et al.
International Journal of Molecular Medicine|August 8, 2002
Prevention of carcinogenesis of mouse mammary epithelial cells RIII/MG by epigallocatechin gallateHiroshi Yanaga, Teruhiko Fujii, Toshihiro Koga, et al.
Journal of Oncology|September 28, 2010
Apparent Diffusion Coefficient in Invasive Ductal Breast Carcinoma: Correlation with Detailed Histologic Features and the Enhancement Ratio on Dynamic Contrast-Enhanced MR ImagesRoka Namoto Matsubayashi, Teruhiko Fujii, Kotaro Yasumori, et al.
Breast Cancer Research and Treatment|June 26, 2004
Identification of HER2/ neu-derived peptides capable of inducing both cellular and humoral immune responses in HLA-A24 positive breast cancer patientsKoichi Azuma, Shigeki Shichijo, Hiroki Shomura, et al.
Cancer Immunology, Immunotherapy : CII|December 20, 2005
Characterization of IL-2-activated TILs and their use in intrapericardial immunotherapy in malignant pericardial effusionUhi Toh, Teruhiko Fujii, Naoko Seki, et al.
The Japanese Journal of Thoracic and Cardiovascular Surgery : Official Publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai Zasshi|January 14, 2004
Spontaneous regression in small cell esophageal carcinomaMasahiro Kubota, Susumu Sueyoshi, Hiromasa Fujita, et al.
International Journal of Molecular Medicine|September 18, 2004
Experimental gene therapy using p21Waf1 gene for esophageal squamous cell carcinoma by gene gun technologyYuichi Tanaka, Teruhiko Fujii, Hideaki Yamana, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 19, 2008
[A case of recurrent breast cancer with bone marrow metastasis treated with weekly paclitaxel therapy]Shinsuke Sasada, Goro Yokoyama, Hiroki Takahashi, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|May 7, 2004
Cyclin-dependent kinase inhibitor, p21Waf1, regulates vascular smooth muscle cell hypertrophyKenichi Okamoto, Seiya Kato, Nobuyuki Arima, et al.
Pageof 6